Joel Greenblatt’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
Joel Greenblatt's IMVT Position: Q3 2026 in Review
Joel Greenblatt sold out of Immunovant (IMVT) in Q3 2026, closing a stake of 30,100 shares — an estimated $1.16M sold.
Joel Greenblatt first reported a position in IMVT in Q3 2023 and held it in 2 quarters. The position peaked at $1.16M in Q2 2026. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- Joel Greenblatt reported no remaining Immunovant position as of Q3 2026 after selling out during the quarter.
- Joel Greenblatt sold 30,100 Immunovant shares in Q3 2026, an estimated $1.16M.
- Joel Greenblatt first reported a position in Immunovant in Q3 2023 and held it in 2 quarters.
- Joel Greenblatt's Immunovant position peaked at $1.16M in Q2 2026.
- 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.